HUMAN DNA VACCINES MARKET ANALYSIS

Human DNA Vaccines Market, by Type (Recombinant Protein Vaccine and Gene Based Vaccine), by Application (HIV, Human Papillomavirus, Influenza, and Others), by End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers, and Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI4987
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Human DNA Vaccines Market: Competitive landscape

The key players operating in the global human DNA vaccines market include GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., Bharat Biotech., Indian Immunologicals Limited, Merck & Co., Inc., GREEN CROSS CORP, Novartis AG, Sanofi, Zoetis, Aldevron, AnGes, Inc., Pfizer Inc., Immunomic Therapeutics, Inc., Inovio Pharmaceuticals, Inc., General Electric, Ichor Medical Systems., VGXI, Inc., Biomay AG, Valneva SE, and GeoVax among other domestic and global players.

HUMAN DNA VACCINES MARKET ANALYSIS

Leading Companies

Human Dna Vaccines Market Report Snapshots

EXISTING CLIENTELE